Reaction

Craniocerebral Injury reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,961 reports · 82 co-occurring drugs

As of the last recalculation, Craniocerebral Injury appears in 2,961 FAERS reports alongside 82 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 13.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Calcium, Magnesium, Potassium, And Sodium Oxybates	16	13.1	13.1
Nebivolol	25	11.1	11.1
Dutasteride	12	10.4	10.4
Dabigatran Etexilate Mesylate	104	10.4	10.4
Dabigatran Etexilate	108	10.1	10.1
Sirolimus	15	7.9	7.9
Lacosamide	40	7.6	7.7
Rizatriptan Benzoate	11	7.6	7.6
Sodium Oxybate	67	7.3	7.3
Brivaracetam	9	7.1	7.1
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	41	7.0	7.0
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	34	6.8	6.8
Fosaprepitant Dimeglumine	13	6.7	6.7
Butalbital, Acetaminophen, And Caffeine	10	6.6	6.6
Pertuzumab	25	6.5	6.5
Buspirone Hydrochloride	10	6.4	6.4
Hydrocodone Bitartrate And Acetaminophen	48	6.1	6.1
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	7	6.0	6.0
Rivastigmine	16	6.0	6.0
Isosorbide Dinitrate	16	5.8	5.8
Memantine	11	5.7	5.7
Memantine Hydrochloride	11	5.7	5.7
Nebivolol Hydrochloride	27	5.7	5.7
Apixaban	53	5.7	5.7
Oxycodone And Acetaminophen Tablets	9	5.3	5.3
Methadone	32	5.3	5.3
Thyroid, Porcine	8	5.3	5.3
Emicizumab	9	5.1	5.1
Cenobamate	6	5.1	5.1
Temozolomide	15	5.0	5.0
Buprenorphine Hydrochloride, Naloxone Hydrochloride	17	5.0	5.0
Lisdexamfetamine Dimesylate	23	4.9	4.9
Abiraterone	9	4.7	4.7
Oxycodone And Acetaminophen	15	4.5	4.5
Amphetamine	5	4.3	4.3
Modafinil	18	3.9	3.9
Levetiracetam	73	3.9	3.9
Brexpiprazole	9	3.8	3.8
Levetiracetam In Sodium Chloride	40	3.7	3.7
Levetiracetam Oral	40	3.7	3.7
Levetiracetam Injection	40	3.7	3.7
Amantadine	8	3.6	3.6
Ethyl Alcohol	14	3.6	3.6
Tafamidis	6	3.6	3.6
Guanfacine	4	3.6	3.6
Iohexol	4	3.4	3.4
Galcanezumab-Gnlm	15	3.4	3.4
Armodafinil	10	3.3	3.3
Erenumab-Aooe	26	3.3	3.3
Peginterferon Beta-1A	6	3.2	3.2
Rasagiline Mesylate	5	3.2	3.2
Testosterone Cypionate	4	3.2	3.2
Tiotropium Bromide Inhalation Spray	5	3.1	3.1
Rivaroxaban	86	3.0	3.0
Isopropyl Alcohol	14	2.9	2.9
Rotigotine	6	2.9	2.9
Oxycodone Hydrochloride	84	2.8	2.8
Esketamine Hydrochloride	7	2.8	2.8
Alcohol	15	2.7	2.7
Cannabidiol	9	2.7	2.7
Ranolazine	4	2.7	2.7
Methadone Hydrochloride	4	2.6	2.6
Somatropin	27	2.6	2.6
Abiraterone Acetate	15	2.6	2.6
Vortioxetine	6	2.5	2.5
Fremanezumab-Vfrm	4	2.5	2.5
Methylphenidate	10	2.4	2.4
Lurasidone Hydrochloride	7	2.4	2.4
Agalsidase Beta	3	2.3	2.3
Dalfampridine	23	2.3	2.3
Mometasone Furoate And Formoterol Fumarate Dihydrate	5	2.3	2.3
Rimegepant Sulfate	4	2.2	2.2
Carfilzomib	8	2.0	2.0
Methoxy Polyethylene Glycol-Epoetin Beta	3	1.9	1.9
Guselkumab	9	1.8	1.8
Benralizumab	5	1.8	1.8
Ixekizumab	9	1.7	1.7
Dimethyl Fumarate	27	1.5	1.5
Buprenorphine	20	1.5	1.5
Valbenazine	4	1.1	1.1
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	4	0.9	0.9
Pimavanserin Tartrate	7	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.